newsfilter
← Latest News
PR Newswire·

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

VANCOUVER, BC, Sept. 18, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE:PREV) (OTCQB:PRVCF) (FSE: 18H), is proud to announce that Endosane Pharmaceuticals GmbH will